# A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study

> **NCT02646683** · PHASE4 · COMPLETED · sponsor: **Geert D'Haens** · enrollment: 260 (actual)

## Conditions studied

- Crohn Disease

## Interventions

- **DRUG:** vedolizumab

## Key facts

- **NCT ID:** NCT02646683
- **Lead sponsor:** Geert D'Haens
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07
- **Primary completion:** 2023-05-26
- **Final completion:** 2023-05-26
- **Target enrollment:** 260 (ACTUAL)
- **Last updated:** 2023-06-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02646683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02646683, "A Study to Evaluate Efficacy, of Early Versus Late Use of Vedolizumab in Crohn's Disease: the LOVE-CD Study". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02646683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*